FIP Statutes
The current statutes of the FIP were adopted by the Council of FIP in Sydney, Australia on Thursday 4th September 2003 and replace the 2002 Statutes.
Click here to download the pdf file of the Statutes.
NAME and HEADQUARTERS
Article 1 - Foundation of FIP
The Tenth International Congress of Pharmacy decided, on September 5, 1910, to group together national pharmaceutical associations, federations and societies in one international association which was to bear the name "Fédération Internationale Pharmaceutique /International Pharmaceutical Federation" (FIP). The Federation was established for an unlimited period. It shall be subject to the national law of the country in which it has its Headquarters. The Headquarters of FIP is located in The Hague, The Netherlands.
MISSION
Article 2
FIP has as its mission "to represent and serve pharmacy and pharmaceutical sciences world wide".
To achieve its mission FIP may:
1. Promote the role of the pharmacist and the pharmaceutical scientist in the field of healthcare;
2. Advocate and support any measures designed to ensure the distribution, supply and proper use of medicines;
3. Collaborate with pharmaceutical organisations seeking FIP's aid to improve pharmaceutical structures in their own countries;
4. Collaborate closely with other organisations, such as the World Health Organisation;
5. Set up regional structures (pharmaceutical forums) in cooperation with the WHO Regional Offices
6. Develop the activities of its Sections and Special Interest Groups;
7. Organise FIP Congresses and, on the proposal of either the Board of Pharmaceutical Sciences or the Board of Pharmaceutical Practice, give support to conferences which are pharmaceutical or related to pharmacy;
8. Publish a journal in order to foster communication between members of FIP;
9. Act as an information centre;
10. Use any other means it deems appropriate.
RULES
Article 3
FIP shall make such rules as are necessary to its activities.
MEMBERS
Article 4 - Categories of members
FIP Comprises:
1. Member Organisations;
2. Observer Organisations;
3. Individual Members;
4. Supporting Members;
5. Honorary Members.
If reference is made to members this is deemed to include all categories of members.
Article 5 - Member Organisations
Member Organisations are: legally constituted organisations representing pharmacists and/or pharmaceutical scientists.
The Council may accept that the pharmaceutical profession or pharmaceutical scientists of a given country may be represented by more than one organisation simultaneously.
Each of these organisations may be admitted as a Member Organisation of FIP.
Article 6 - Observer Organisations
On proposal of the Bureau, the Council may grant Observer Organisation status to those organisations that have an interest in the work of the Council, and whom FIP has a clear interest to work with, but who do not meet the Member Organisation requirements.
Article 7 - Other Members
Individual Members are: persons wishing to contribute to the development of FIP.
Supporting Members are: non-commercial organisations or societies wishing to support the activities of FIP.
Article 8 - Honorary Members
The Council, on the proposal of the Bureau, may award the title of: Honorary President to former Presidents of FIP who have given exceptional service to FIP. The Bureau may award the title of Honorary Member, to persons who have rendered significant service to FIP.
Honorary Presidents may attend Council Meetings, but do not have voting rights.
Article 9 - Admission of members
1. An organisation of a country seeking admission as a Member Organisation must submit its application in writing to the General Secretary. After consulting its Member Organisation(s) in the country concerned and the Bureau, the President may invite the applicant to be represented provisionally by an observer at the next Council Meeting.
At the same Council Meeting, the Council shall declare its stand on the application for admission.
In cases where there is a lack of clarity as to whether organisations represent pharmacists and/or pharmaceutical scientists, directly or indirectly, the Bureau will judge the application and forward to the Council those applications for membership that are in line with FIP's mission and demonstrate a clear benefit to FIP and its Member Organisations. The Council will then decide on admission.
2. An organisation seeking admission as an Observer Organisation must submit its application in writing to the General Secretary. The General Secretary will consult the Executive Committee and forwards the application to the Bureau. The Bureau will prepare a recommendation for the Council and at the Council Meeting the Council shall declare its stand on the application for admission.
3. An applicant seeking admission for one of the other membership categories must submit the application in writing to the General Secretary. Valid applications shall be accepted. However, the Bureau shall have the right to refuse admission.
Article 10 - Loss of membership
1. Members may withdraw from FIP, at the end of a calendar year, provided they notify the General Secretary of their intention in writing at least one year in advance of the end of the calendar year.
2. On the proposal of the Bureau, the Council may exclude from FIP Member Organisations or Observer Organisations who do not honour their financial obligation, or who prove unworthy of membership.
3. Categories of other Members who fail to pay their membership fees, following a proper demand, or prove unworthy of membership may be excluded from membership from a date to be set by the Executive Committee.
ORGANS
Article 11
The organs of FIP are:
1. the Assembly of Pharmacists and Pharmaceutical Scientists;
2. the Council;
3. the Bureau;
4. the Executive Committee;
5. the Board of Pharmaceutical Sciences;
6. the Board of Pharmaceutical Practice; (jointly "the Boards")
7. the Sections;
8. the Secretariat.
The Council may create other organs whose activities are essential to FIP. Rules for the governing of all organs shall have received the approval of the Council.
THE ASSEMBLY OF PHARMACISTS AND PHARMACEUTICAL SCIENTISTS (the Assembly)
Article 12 - Composition
The Assembly is composed of all members of FIP in an individual capacity.
Assemblies
The Assembly is held at least every second year. It is summoned by the President on the proposal of the Bureau.
Venues for Assemblies
The Bureau, on the proposal of the Executive Committee, designates the place where these Assemblies shall be held.
Role and powers of the Assembly
The principle purpose of the Assembly is informative. The Council outlines its policies. It informs the Assembly of its choices in respect of the elections to the position of President and Vice President of FIP and regarding the admission of new (Associate) Member Organisations.
The Assembly takes cognisance of the activity reports of the Bureau, the Council, the Boards and the Sections. After receiving the various reports of the organs of FIP, the Assembly proceeds to a broadly based discussion during which members may express their individual views.
The President of FIP may, if he deems it necessary, submit a decision of the Council to a consultative vote of the Assembly. If the vote reveals a significant opposition (more than one third of the votes of the participants), the President may refer the contested decision back to the Council. The Council will then be obliged to re-open the discussion on the decision.
It may either maintain it unchanged or modify it taking into account the view expressed by the Assembly. In either case the new decision of the Council shall be final. The decision will be made known to all members.
THE COUNCIL
Article 13 - Composition
The Council comprises:
1. The members of the Bureau;
2. The representatives of the Member Organisations with one delegate admitted for each organisation;
3. The representatives of the Observer Organisations with one delegate admitted for each organisation;
4. A representative from each of the Boards, in principle the Chairman;
5. A representative from each of the Sections;
6. Honorary Presidents.
Article 14 - Voting rights and weighted voting
1. The members of the Bureau: 1 vote per member
2. The delegates of the Member Organisations, according to the following criteria
- Member Organisations serving 249 pharmacists and pharmaceutical scientists or less: 1 vote
- Member Organisations serving 250 to 499 pharmacists and pharmaceutical scientists: 2 votes
- Member Organisations serving 500 to 999 pharmacists and pharmaceutical scientists: 3 votes
- Member Organisations serving 1,000 to 1,999 pharmacists and pharmaceutical scientists: 4 votes
- Member Organisations serving 2,000 to 2,999 pharmacists and pharmaceutical scientists: 5 votes
- Member Organisations serving 3,000 to 4,999 pharmacists and pharmaceutical scientists: 6 votes
- Member Organisations serving 5,000 to 9,999 pharmacists and pharmaceutical scientists 7 votes
- Member Organisations serving 10,000 to 19,999 pharmacists and pharmaceutical scientists: 8 votes
- Member Organisations serving 20,000 to 29,999 pharmacists and pharmaceutical scientists: 9 votes
- Member Organisations serving 30,000 or more pharmacists and pharmaceutical scientists: 10 votes
3. The representative of the Board of Pharmaceutical Sciences: 5 votes
4. The representative of the Board of Pharmaceutical Practice: 5 votes
5. The representatives of the Section: 5 votes per Section
6. Honorary Presidents have a right to attend Council meetings but have no voting rights
7. The delegates of Observer Organisations have a right to attend the Council Meeting but have no voting rights.
No one may delegate his/her vote(s) to another member. It is the responsibility of the Member Organisations, the Boards and the Sections to appoint delegates to the Council.
Article 15 - Functions of the Council
The Council takes all decisions relating to professional and scientific policy which shall be presented to the Assembly of Pharmacists and Pharmaceutical Scientists and which the Bureau is required to implement. Notably:
1. On the proposal of the Bureau, it appoints the President and the Vice-Presidents.
2. After election by the Board of Pharmaceutical Sciences it ratifies the appointment of the Chairman of that body. Similarly it ratifies the Scientific Secretary.
3. After election by the Board of Pharmaceutical Practice it ratifies the appointment of the Chairman of that body. Similarly it ratifies the Professional Secretary.
4. After election by the Board of Pharmaceutical Sciences it ratifies the appointment of the two BPS Vice Presidents of the Bureau.
5. After election by the Board of Pharmaceutical Practice it ratifies the appointment of the two BPP Vice Presidents of the Bureau.
6. On the proposal of the Bureau or where applicable the Boards: The removal of an elected officer during a term of office on the grounds of incompetence, inactivity, conflict of interest, activity incompatible with the aims and objectives of FIP or criminal activity.
7. It receives the activity reports of the Bureau, both Boards and the Sections. All these reports are sent to the Bureau, which forwards them to the Council.
8. It receives proposals of general interest from the various organs of FIP, with a note from the Bureau.
9. It discusses and adopts the financial report and fixes the rates for membership fees for the Member Organisations.
10. It admits Member Organisations and Observer Organisations.
11. It elects Honorary Presidents on the proposal of the Bureau.
12. It may exclude a Member Organisation or Observer Organisation, according to Article 10, paragraph 2 of the Statutes.
13. It approves the creation of new Sections of FIP.
14. It may set up Committees to study particular problems.
15. It approves the rules of FIP, the Council, the Bureau, the Boards and the Sections.
16. It modifies the statutes of FIP. Such modification must obtain at least two thirds of the votes in Council in favour of these modifications.
17. The Council decides on whether or not a Member Organisation is Predominantly Scientific (see Article 20).
18. The Council decides on the dissolution of FIP after consulting the Assembly of Pharmacists and Pharmaceutical Scientists.
Article 16
Excepting in the cases cited in Article 15 (point 16) and Article 26 of the Statutes, decisions taken in Council are taken by simple majority vote, weighted as set out in Article 13. The General Secretary despatches the agenda for the Council, accompanied by the reports pertaining to it, to the members of the Council at least six weeks prior to the meeting. Any proposal intended for the Council agenda must reach the General Secretary - together with a brief explanatory note - three months prior to the date of the meeting. The President may include on the Council agenda items arriving after the prescribed deadline of three months, if he deems them urgent. Members of the Council may enter a plea of urgency for a proposal not included in the agenda. The Council shall decide on whether or not discussion of the item is appropriate. A report of the Council's deliberation is drawn up. Members of the Council shall receive a report containing the text of all decisions taken.
Meetings
The Council meets once a year, or when the President or the majority of the members deem it necessary.
BUREAU
Article 17 - Composition
The Bureau is composed of the Executive Committee members together with the Immediate Past President, the Chairman of the Board of Pharmaceutical Sciences, the Chairman of the Board of Pharmaceutical Practice and nine Vice-Presidents.
The Bureau proposes (to the Council) candidate(s) for the Presidency.
As far as possible, the Vice-Presidents should be chosen in such a manner as to ensure that all parts of the world are represented. Five of the Vice-Presidents shall be appointed by the Council from amongst those proposed by the Bureau (who, in turn, receive proposals for candidates from the Member Organisations). Two Vice-Presidents shall be ratified by the Council after proposition by the Board of Pharmaceutical Sciences and two Vice Presidents shall be ratified by the Council after proposition by the Board of Pharmaceutical Practice.
A representative of the pharmaceutical forum, as mentioned in article 2 point 5, may attend the Regular Bureau Meeting as observer.
Duration of terms of office
The President, the Chairman of the Board of Pharmaceutical Sciences, the Chairman of the Board of Pharmaceutical Practice, the Scientific Secretary and the Professional Secretary, as well as the Vice-Presidents, are elected for four years. Vice-Presidents, together with the Scientific and Professional Secretaries, may be re-elected for only one further term of four years whilst the President and the Chairmen of the two Boards shall only serve one term of office.
The Immediate Past President's term of office shall be from the election of his successor and for a period of four years.
Functions
The Bureau has the following functions:
1. to implement the decisions of the Council.
2. to facilitate relations between the Council and those persons or bodies having been assigned a special task.
3. to appoint the General Secretary.
4. to propose to the Council candidates for the five Vice Presidents (and who, in turn, receive proposals from the Member Organisations).
5. to determine the venues of FIP Congresses.
6. to propose to Council the annual rate of membership fees for Member Organisations.
7. to determine the annual rate of membership fees for Individual and Supporting Members and Observer Organisations
8. to forward to the Council the activity reports of the various organs of FIP as well as any proposals it receives, when it deems them of general interest. These may be accompanied by a note or comment.
9. to exclude individual or supporting members in accordance with Article 9 (point 3).
10 to award the title of Honorary Member to persons who have rendered significant service to FIP.
Meetings
The Bureau meets once a year or more frequently if the President or a majority of members deem it necessary. Decisions taken in the Bureau are taken by a simple majority vote, unless otherwise prescribed in these Statutes.
Representation
The Bureau is the legal representative of FIP.
Furthermore FIP is represented by the President and the General Secretary acting jointly.
PRESIDENT
Article 18 - Role
The President of FIP is Chairman of the Council and of the Bureau. He is ex-officio a member of the Board of Pharmaceutical Sciences and of the Board of Pharmaceutical Practice.
He is ex-officio a member of the Executive of each of the Sections. He is Chairman of the Executive Committee.
SECRETARIAT
Article 19 - Composition and role
The Secretariat comprises the General Secretary, the Scientific Secretary and the Professional Secretary.
The General Secretary handles, under the supervision and according to the dictates of the Executive Committee and the President, FIP's operations. In particular, he is responsible, in agreement with the President, for all staff matters, the management of financial affairs, for keeping records, for summoning members to meetings and for implementing the decisions of the organs of FIP.
The General Secretary must keep current the list of the members of FIP, of
members of the Council and the Sections. The General Secretary is in regular contact with the President. The General Secretary is an ex officio member of all organs of FIP, but without voting rights.
The General Secretary shall be responsible for the administrative and logistical arrangements for FIP Congresses and Conferences.
The Scientific Secretary, under the supervision and according to the dictates of the Executive Committee and the President, handles the organisation of FIP's scientific activities, in particular the arrangement of the scientific programmes at FIP Congresses and conferences. The Professional Secretary, under the supervision and according to the dictate of the Executive Committee and the President, handles the organisation of FIP's professional activities, in particular the arrangement of the professional programmes at FIP Congresses and conferences.
BOARD OF PHARMACEUTICAL SCIENCES
Article 20 - Composition
The Board of Pharmaceutical Sciences comprises the:
• The Executive of the Board
• The two Vice Presidents of the Bureau nominated by the BPS
• The Chairmen of the Special Interest Groups (SIGs)
• Representatives of Predominantly Scientific Member Organisations (PSMO)
• Representatives of Predominantly Scientific Observer Organisations (PSOO)
• Representatives of International Scientific Organisations (ISO),
together with up to 15 persons (Expert Members) chosen by the Board itself, to represent current and emerging sectors of pharmaceutical sciences.
Predominantly Scientific Member Organisations (PSMO) are Member Organisations devoted predominantly to pharmaceutical sciences.
Predominantly Scientific Observer Organisations (PSOO) are Observer Organisations devoted predominantly to pharmaceutical sciences.
International Scientific Organisations (ISO) are recognised global scientific societies.
Predominantly Scientific Member Organisations (PSMO) and International Scientific Organisations (ISO) shall have representation on the Board as follows:
• 1,000 or less - 1 representative
• 1,001 - 2,500 - 2 representatives
• over 2,500 - 3 representatives
Predominantly Scientific Observer Organisations (PSOO) shall have 1 representative.
Chairman of the Board
The Board appoints a Chairman, chosen from its members. This appointment is forwarded to the Council for ratification. The Chairman of the Board is appointed for a period of four years.
Scientific Secretary
The Board appoints the Scientific Secretary after an election and forwards this appointment to the Council for ratification. The Scientific Secretary serves for a period of four years and may be re-appointed for one additional period of four years. The Scientific Secretary serves as Secretary of the Board.
Executive of the Board
The Executive shall consist, ex officio, of the Chairman of the Board, the Immediate Past Chairman, the Scientific Secretary and the Professional Secretary together with two members elected by the Board from amongst its members.
The term of office for the two elected members shall be four years with the possibility of re-election for an additional term of four years.
Additional Members of the Board
The Board may appoint (as described earlier) up to a maximum of 15 additional members to represent the different areas of Pharmaceutical Sciences.
They are nominated by agreement between the Chairman and the Scientific Secretary. They are appointed for a period of four years with the possibility of re-appointment for an additional period of four years.
Role of the Board
The task of the Board is to handle all scientific aspects of FIP's activities.
The Board is responsible for the preparation of the scientific programmes of the Congresses and, where applicable, other conferences of FIP. It maintains contacts with relevant interested parties and may assist in the co-ordination of scientific activities of the Sections. It may organise specialised meetings in the field of pharmaceutical sciences. It co-ordinates the scientific activities of FIP in the latter's relations with other scientific organisations. It is responsible for the selection of the recipient of the Høst-Madsen medal.
In addition it is entitled to formulate policy and mission statements within the realms of its responsibility. Before release, however, it has to hear the opinion of both the Board of Pharmaceutical Practice and the Bureau.
Finance
The Board shall, in co-operation with the General Secretary, be responsible for preparing an annual budget. The Board's income shall consist of a proportion of the membership fees of the Predominantly Scientific Member Organisations, together with the net profit (or loss) from conferences or other activities organised by it or income from other sources. It shall produce an annual financial report which shall be forwarded to the Council. Proper accounting shall be the responsibility of the General Secretary. The Board's finances shall be contained in the overall accounts of FIP.
Special Interest Groups
The Board may form Special Interest Groups (SIG) and appoints the members of the SIG to look into specific problems or to bring together expertise in a specific area of interest. The Chairman of any SIG is a member of the Board . Membership of SIGs shall be open only to individual members of FIP. SIG's may, with the approval of the Bureau, charge a fee for membership. Each SIG shall draw up its own rules, which must be approved by the Board before the rules become effective.
BOARD OF PHARMACEUTICAL PRACTICE
Article 21 - Composition
The Board of Pharmaceutical Practice comprises of the Executive of the Board, the two Vice Presidents of the Bureau nominated by the BPP, the President and Secretary of each Section together with a maximum of 10 experts members appointed by the Board itself to represent different sectors of the pharmaceutical profession.
Where a Section has more than 500 members it shall be allowed to have an additional representative on the Board.
Chairman of the Board
The Board appoints a Chairman, chosen from its members. This appointment is forwarded to the Council for ratification. The Chairman of the Board is appointed for a period of four years.
Professional Secretary
The Board appoints the Professional Secretary after an election and forwards this appoinment to the Council for ratification. The Professional Secretary serves for a period of four years and may be re-appointed for one additional period of four years. The Professional Secretary serves as Secretary to the Board.
Executive of the Board
The Executive shall consist of, ex officio, the Chairman of the Board, the Immediate Past Chairman, the Professional Secretary and the Scientific Secretary together with two members elected by the Board from amongst its members. The term of office for the two elected members shall be four years with the possibility of re-election for an additional term of four years.
Additional Members of the Board
The Board may appoint (as described earlier) up to 10 additional members to represent the different sections of the pharmaceutical profession. They are nominated by agreement between the Chairman and the Professional Secretary. They are appointed for a period of four years with the possibility of reappointment for an additional period of four years.
Role of the Board
The task of the Board is to handle all professional aspects of FIP's activities.
The Board is responsible for the preparation of the professional programmes of the Congress and, where applicable, other conferences of FIP. It maintains contact with the relevant interested parties and may assist in the co-ordination of professional activities of the Sections.
It co-ordinates the professional activities of FIP in the latter's relations with other professional organisations.
In addition it is entitled to formulate policy and mission statements within the realms of its responsibilities.
Before release, however, it has to hear the opinion of both the Board of Pharmaceutical Sciences and the Bureau.
The Board, where it deems it necessary, may set up working parties where the subject matter is outside the responsibility of any of the Sections or covers the interest of more than one Section.
It is not envisaged that these working parties are permanent in nature - lasting only as long as necessary to produce a report.
The Board may, with the approval of Council, set up or disband Sections.
The Board shall be responsible for the selection of the recipient of the André Bédat Award.
Finance
The Board shall, in co-operation with the General Secretary, be responsible for preparing an annual budget. The Board's income shall consist of a part of the membership fees of the Member Organisations (who are not Predominantly Scientific) together with the net profit/loss from conferences and other activities organised by it or the income from other sources. It shall produce on annual financial report, which shall be forwarded to the Council. Proper accounting shall be the responsibility of the General Secretary. The Board's finances shall be contained in the overall accounts of FIP.
THE SECTIONS
Article 22 - Constitution
The Board of Pharmaceutical Practice may, with the approval of the Council, set up Sections representing Professional Groups. Individual members of FIP may choose the Section(s) to which they wish to apply.
Rules of the Sections
Each Section shall draw up rules under which it shall operate. The rules must be approved by Council before they become effective. Sections may, with the approval of the Bureau, charge a fee for membership.
Activities
The Sections may organise specialised professional and scientific conferences with the Board of Pharmaceutical Practice and the Board of Pharmaceutical Sciences respectively acting as the co-ordinating body should they do so. However, at Congresses each Section must hold its annual meeting
The activity reports of the Sections must reach the General Secretary at least three months before the date set for the meeting of the Council.
Recommendations and Resolutions
Recommendations and resolutions of Sections may acquire official status only when approved by the Council.
THE EXECUTIVE COMMITTEE
Article 23 - Composition
The Executive Committee is composed of the President, the Scientific Secretary and the Professional Secretary.
Functions
The Executive Committee prepares, proposes and co-ordinates all the activities of FIP. It refers these matters to the Bureau.
Sessions
The Executive Committee meets as required by the President or a majority of its members. It may invite to its meeting any person whom its considers necessary.
FINANCES
Article 24
The financial year of FIP shall be the calendar year.
The financial resources of FIP comprise:
1. Membership fees;
2. Donations, voluntary contributions or requests from individuals, societies, pharmaceutical firms or other institutions;
3. Section and Special Interest Group membership fees.
4. Results of special activities of FIP.
The membership fees are payable before the end of the first quarter of each year. If, after a reminder, the payment has not been made the General Secretary shall take all possible steps to recover the outstanding fees.
Although part of the overall resources of FIP, the membership fees for Sections
and/or Special Interest Groups require special mention. These fees shall be collected centrally but shall be remitted, without any deduction, to the Section or Special Interest Group concerned.
In the annual meeting of the Council, the Bureau presents the annual report and the audited annual accounts and reports on the affairs and conduct of business of FIP in the past financial year.
The annual accounts shall be audited by a reputable firm of accountants to be
appointed by the Bureau. The accountant shall examine the annual accounts, report there on to the Bureau, and submit an opinion with regard thereto. This report shall also be presented to the Council.
Net worth
The net worth of FIP shall consist of all of the assets of FIP less foreseen liabilities. The net worth shall include the assets and liabilities of the Boards, Sections and Special Interest Groups.
The annual membership fees for the Observer Organisations are fixed by the Bureau.
GENERAL PROVISIONS
Article 25 - Limitation of FIP
FIP shall not interfere in matters which properly are the responsibility of national associations.
MODIFICATION OF STATUTES
Article 26
Modification does not come into force until after such modification has been laid down in a notarial deed.
Any member of the Executive Committee of FIP or the General Secretary shall have the authority to sign the notarial deed.
Article 27 - Liquidation of FIP - Procedure
A proposal to dissolve FIP must come from the Council and it must be submitted to the Assembly of Pharmacists and Pharmaceutical Scientists.
Procedure
The procedure shall be as follows:
a first vote shall take place in Council. if at least two thirds of the weighted votes are in favour of the dissolution, the Assembly of Pharmacists and Pharmaceutical Scientists must declare its decision. If, at this Assembly, two thirds of Individual Members are also in favour of dissolution, the proposal reverts to the Council for a final decision.
The latter is obtained if, once again, there is a majority of two thirds of the
weighted votes.
The announcement of meetings for this purpose shall be sent to Member Organisations by registered mail, and to other members through the FIP Journal.
In the event of half of the Member Organisations not being represented at the last session of the Council, no vote shall be taken. The question shall then be submitted in writing to all those with voting rights.
Article 28 - Liquidation of FIP - General Provisions
The liquidation of FIP, upon the dissolution, shall be effected by the Executive Committee. After the finalisation of the liquidation, the books and records of FIP shall for ten years remain in the custody of a person to be appointed for that purpose by the Council in the resolution to dissolve
FIP. If no such appointment has been made by the Council, this appointment shall be made by the liquidators.
Article 29 - Assets of FIP in the event of dissolution
In the event of dissolution of FIP all its assets shall pass to the government of the country in which FIP has its headquarters at the time of dissolution, with a directive to the latter that they are to be used for the benefit of an international organisation with aims similar to those of FIP.
Article 30 - General Provision
In all events not foreseen by the Statutes or any other governing rules, or where these are considered unclear, the Bureau will decide or, if its so wishes, may defer the decision to the Council. All such decisions must be in accordance with the laws of the country in which FIP has its headquarters.
